The mitral to aortic/pulmonary velocity-time integral ratio is a simple, feasible and accurate discriminator for echocardiographic evaluation of severe isolated mitral regurgitation.

Autor: Nerlekar N; Monash Cardiovascular Research Centre, Monash University and Victorian Heart Hospital, Monash Health, Clayton, VIC, Australia.; Baker Heart and Diabetes Institute, Melbourne, VIC, Australia., Ramkumar S; Monash Cardiovascular Research Centre, Monash University and Victorian Heart Hospital, Monash Health, Clayton, VIC, Australia., Maggiore P; Monash Cardiovascular Research Centre, Monash University and Victorian Heart Hospital, Monash Health, Clayton, VIC, Australia., Teng J; Monash Cardiovascular Research Centre, Monash University and Victorian Heart Hospital, Monash Health, Clayton, VIC, Australia., Cimenkaya C; Monash Cardiovascular Research Centre, Monash University and Victorian Heart Hospital, Monash Health, Clayton, VIC, Australia., Be KK; Monash Cardiovascular Research Centre, Monash University and Victorian Heart Hospital, Monash Health, Clayton, VIC, Australia., Baumann A; Monash Cardiovascular Research Centre, Monash University and Victorian Heart Hospital, Monash Health, Clayton, VIC, Australia., Nicholls SJ; Monash Cardiovascular Research Centre, Monash University and Victorian Heart Hospital, Monash Health, Clayton, VIC, Australia., Moir S; Monash Cardiovascular Research Centre, Monash University and Victorian Heart Hospital, Monash Health, Clayton, VIC, Australia. Stuart.moir@monashhealth.org.
Jazyk: angličtina
Zdroj: The international journal of cardiovascular imaging [Int J Cardiovasc Imaging] 2024 Dec; Vol. 40 (12), pp. 2459-2467. Date of Electronic Publication: 2024 Oct 17.
DOI: 10.1007/s10554-024-03249-x
Abstrakt: Echocardiographic quantification of mitral regurgitation (MR) remains challenging, requiring dedicated image acquisition, and is limited by potential error from geometric assumptions of annular dimensions. Volume is a product of area and flow and assuming proportional mitral/aortic areas, an increased mitral-inflow volume compared to LV/RV-outflow semi-quantitatively represents greater MR regurgitant volume. Therefore, we investigated the feasibility and diagnostic performance of the mitral-aortic velocity-time integral(VTI) ratio in isolated MR. We also investigated the use of the mitral-pulmonary VTI ratio as an alternative in clinical situations where the LV outflow tract(LVOT) VTI could not be used. We reviewed 166 consecutive patients (33%, n = 54 severe MR by multi-parameter integrated expert opinion). Pulsed wave Doppler VTI at the mitral leaflet tips and the left ventricular outflow and continuous-wave Doppler of the RV outflow tract were measured individually and independently by blinded readers(expert and trainee status) to derive the ratio. Receiver operator characteristic area under the curve(AUC) comparison was calculated and compared with effective regurgitant orifice area(EROA > 40 mm), regurgitant volume(RVol > 60mL), vena contracta(VC > 0.7 cm), E-velocity > 1.2 cm, systolic flow reversal(SFR), left atrial and ventricular dilatation. Increasing ratio was associated with severe MR(AUC 0.94) with optimal threshold defined at 1.3. This provided significant discrimination for severe MR(AUC 0.81) compared to EROA(0.68), VC(0.52), LV dilatation(0.69), LA dilatation(0.70), SFR(0.73), E-velocity(0.68) all p < 0.05, with sensitivity 82% and specificity 94%. The mitral-pulmonary VTI ratio demonstrated similar discrimination(AUC 0.92) with optimal threshold defined at 1.14. Excellent inter-observer reproducibility(intra-class correlation 0.97) was seen between trainee and expert readers. There was no difference in AUC comparison by MR mechanism or patient rhythm. The mitral-aortic and mitral-pulmonary VTI ratios are simple, geometric-free parameters feasibly reproducible from routine echocardiographic datasets and are excellent discriminative tools for severe MR. Readers should consider integration of this parameter in routine reporting.
Competing Interests: Declarations. Competing interests: The authors declare no competing interests.
(© 2024. The Author(s).)
Databáze: MEDLINE
Externí odkaz: